1. Home
  2. MXCT vs HYI Comparison

MXCT vs HYI Comparison

Compare MXCT & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • HYI
  • Stock Information
  • Founded
  • MXCT 1999
  • HYI 2010
  • Country
  • MXCT United States
  • HYI United States
  • Employees
  • MXCT N/A
  • HYI N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HYI Investment Managers
  • Sector
  • MXCT Health Care
  • HYI Finance
  • Exchange
  • MXCT Nasdaq
  • HYI Nasdaq
  • Market Cap
  • MXCT 242.4M
  • HYI 270.9M
  • IPO Year
  • MXCT 2021
  • HYI N/A
  • Fundamental
  • Price
  • MXCT $1.40
  • HYI $11.90
  • Analyst Decision
  • MXCT Buy
  • HYI
  • Analyst Count
  • MXCT 4
  • HYI 0
  • Target Price
  • MXCT $7.50
  • HYI N/A
  • AVG Volume (30 Days)
  • MXCT 1.2M
  • HYI 50.6K
  • Earning Date
  • MXCT 08-06-2025
  • HYI 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • HYI 9.59%
  • EPS Growth
  • MXCT N/A
  • HYI N/A
  • EPS
  • MXCT N/A
  • HYI N/A
  • Revenue
  • MXCT $35,754,000.00
  • HYI N/A
  • Revenue This Year
  • MXCT N/A
  • HYI N/A
  • Revenue Next Year
  • MXCT $14.79
  • HYI N/A
  • P/E Ratio
  • MXCT N/A
  • HYI N/A
  • Revenue Growth
  • MXCT N/A
  • HYI N/A
  • 52 Week Low
  • MXCT $1.26
  • HYI $10.99
  • 52 Week High
  • MXCT $5.20
  • HYI $12.24
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 31.00
  • HYI 44.98
  • Support Level
  • MXCT $1.37
  • HYI $11.83
  • Resistance Level
  • MXCT $1.48
  • HYI $11.98
  • Average True Range (ATR)
  • MXCT 0.09
  • HYI 0.09
  • MACD
  • MXCT 0.02
  • HYI -0.01
  • Stochastic Oscillator
  • MXCT 46.43
  • HYI 25.00

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: